-
Target Audience
Practicing academic and community pathologists, and pathologists-in-training
-
Learning Objectives
Upon completion of this educational activity, learners will be able to:
- Become familiar with new and rare disease entities involving blood and hematopoietic tissues
- Understand the changes caused by reactive and specific infectious agents in hematopoietic tissues
- Understand the spectrum of Hodgkin lymphoma and its mimics
- Incorporate the clues and ancillary techniques to differentiate neoplastic from reactive proliferations in blood, bone marrow, lymph nodes, spleen and extranodal hematopoietic tissues
Program :
Course Program
- Benign and Neoplastic Disorders Initially Encountered on Blood Smears – M. Kathryn Foucar, MD
- Myeloid and Lymphoid Neoplasms and Lookalikes in Bone Marrow – M. Kathryn Foucar, MD
- Classic Hodgkin Lymphoma and Nodular Lymphocyte Predominant Hodgkin Lymphoma and Challenges with Diagnosis and Overlapping Entities – Rebecca L. King, MD
- Challenges With EBV-Related B Cell Lineage Lymphomas/Lymphoproliferations and Their Classification – Rebecca L. King, MD
- Splenic Tumors and Tumor-Like Proliferations – Daniel A. Arber, MD
- Mixed Bag of Hematologic Neoplasms (Examples of New and Novel Entities) – Daniel A. Arber, MD
- Subtle Reactive and Infectious Lymphoid Proliferations – Girish Venkataraman, MD, MBBS
- Diagnosing Castleman and Castleman-Like Lymphoid Proliferations – Girish Venkataraman, MD, MBBS
Course date: The USCAP Challenges in Hematopathology programme was held April 12–14, 2022.
Source and access note: Course identity and dates were checked against USCAP’s official previous-meetings archive. Official registration benefits are separate from the files delivered by MedicalAmboss via Google Drive; CME credit and a certificate are not included.
